Home/Ethris/Dr. Carsten Rudolph
DC

Dr. Carsten Rudolph

Chief Executive Officer

Ethris

Ethris Pipeline

DrugIndicationPhase
ETH47 (with Vertex)Cystic FibrosisPre-clinical/Phase 1
ETH42Primary Ciliary Dyskinesia (DNAI1 deficiency)Pre-clinical
AstraZeneca Collaboration ProgramsRespiratory Viral Infections (e.g., Influenza, RSV)Discovery/Pre-clinical